Viewing Study NCT01262235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2026-01-13 @ 11:33 AM
Study NCT ID: NCT01262235
Status: COMPLETED
Last Update Posted: 2019-01-16
First Post: 2010-12-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
Sponsor: Arbutus Biopharma Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Neuroendocrine Tumors View
None NET View
None Adrenocortical Carcinoma View
None ACC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumor View
None Non-Hodgkin's Lymphoma View
None Hodgkin's Disease View
None Neuroendocrine tumors (NET) View
None Adrenocortical carcinoma (ACC) View
None Carcinoid View